April 20, or 4/20, is a day when many people across the world celebrate marijuana culture by toking up, jamming out to tunes and filling up on munchies.
But the American Civil Liberties Union (ACLU) is using the unofficial cannabis holiday to draw attention to a serious issue: Despite the growing number of states that are enacting legalization laws, people of color are still much more likely to be arrested for marijuana than white people are—even though consumption rates are virtually identical across races.
In a new report released on Monday, ACLU reveals that while overall arrests are way down in states that have ended prohibition, racial disparities in remaining enforcement persist in those places. Meanwhile, some still-criminalized states are arresting black people for cannabis at almost ten times the rate that whites are busted.
Here are the key findings of the report—“A Tale of Two Countries: Racially Targeted Arrests in the Era of Marijuana Reform”—which is a follow-up to a similar study the organization released in 2013 that drew broad attention to unfair cannabis arrests rates at a time when legalization was just starting to become a major issue in American politics:
Marijuana Arrests Are Still Widespread Across The U.S.
Marijuana arrests nationally are down 18% since 2010, but there has been an uptick since 2015—even though more states are enacting legalization or decriminalization policies.
Cannabis arrests accounted for 43 percent of all drug arrests in 2018, the most recent year the report covers, and an overwhelming majority of those arrests—89.6 percent—were for possession alone.
Extreme Racial Disparities In Marijuana Enforcement Persist
Overall, black people are 3.64 times more likely than white people to be arrested for marijuana possession, even though usage rates are comparable. The trend toward legalization and decriminalization hasn’t reduced national trends in disparate enforcement—and in some parts of the country, they have worsened.
African Americans are more likely to be arrested for marijuana possession in every single state in the country.
“Racial disparities in marijuana possession arrests exist across the country, in every state, in counties large and small, urban and rural, wealthy and poor, and with large and small Black populations,” the report says. “Indeed, in every state and in over 95 percent of counties with more than 30,000 people in which at least 1 percent of the residents are Black, Black people are arrested at higher rates than white people for marijuana possession.”
Marijuana Arrests Decrease After Decriminalization, But Drop More Sharply In Fully Legalized States
Not surprisingly, states that legalized cannabis saw decreases in marijuana possession arrests—though ACLU found that some of these had been experiencing a downward trend even before prohibition was ended.
States with less far-reaching policies that simply decriminalize possession also see reductions in arrests, but not as much as in those places where prohibition is ended altogether. Cannabis possession bust rates are roughly eight times higher in decriminalized states than in ones that have fully legalized, though they are lower than in those where broad criminalization is still the law.
When it comes to arrests for selling marijuana, states with legalization saw an 81.3 percent drop between 2010 and 2018, while decriminalized states experienced a 33.6 percent reduction over that period.
Racial Disparities Persist Even Legalized Or Decriminalized States
Even while overall marijuana arrests are down in legalized and decriminalized states, black people are still much more likely to be busted for cannabis than white people are. “In every state that has legalized or decriminalized marijuana possession, Black people are still more likely to be arrested for possession than white people,” ACLU found.
“Most jurisdictions that have enacted progressive marijuana policy have failed to do so from a foundation of racial justice,” the report warns. “As such, though legalization and decriminalization appear to reduce the overall number of marijuana possession arrests for black and white people alike, such laws have not substantially reduced, let alone eliminated, the significantly larger arrest rates of black people.”
While on average legalized states have lower racial disparities in marijuana possession arrests compared those that have only decriminalized or where prohibition is in full force, Maine and Massachusetts—which both voted to legalize cannabis in 2016—had larger racial disparities in 2018 than they did in 2010.
“The one common finding across every state and the vast majority of counties is that black people are more likely to be arrested for possessing marijuana than white people, regardless of whether possession is illegal, legal, or decriminalized in their state,” the report concludes.
ACLU also reported that shortcomings in police data make it hard to get a full understanding of the unfair impact marijuana enforcement has across racial lines. For example, FBI arrest numbers do not distinguish between Latinos and those of other races, obscuring the particular impact that prohibition has on brown as well as black people.
Along with the report, ACLU launched an online tool that makes it easy for people to see just how discriminatory marijuana enforcement practices are in their own states.
Montana is the worst offender, with black people there being 9.6 times more likely to be arrested for marijuana than white people. Kentucky was not far behind with a disparate rate to the tune of 9.4.
In Colorado, the state with the least discriminatory enforcement rate, African Americans are still 1.5 times more likely to be busted for cannabis than white people are.
Zooming in further to the county level, ACLU found that even within states there are vast differences in how cannabis laws are being enforced.
In Franklin County, Massachusetts, a black person is 117 times more likely to be busted for marijuana possession than a white person is.
“The U.S. has waged a failed, devastating, decades-long war on drugs, including marijuana, in specific communities. Rounding up hundreds of thousands of people every year—millions every decade—for marijuana offenses, this racist campaign has caused profound and far-reaching harm on the people arrested, convicted, and/or incarcerated for marijuana offenses,” ACLU said. “Such harm cannot be undone, but as a country we can acknowledge, repair, and rebuild so that our future looks nothing like our prohibitionist past.”
Looking ahead, the organization is recommending that the federal and state governments legalize marijuana, but that they not stop there. In addition to expunging prior convictions and granting clemency to people still incarcerated on cannabis changes, the group is urging that newly legal markets be made equitable and accessible to people from communities that have been most harmed by the war on drugs.
It’s past time that we not just legalize marijuana, but do so in a way that tackles racial disparities head-on.
The MORE Act will do just that.
— ACLU (@ACLU) April 20, 2020
“The question no longer is whether the U.S. should legalize marijuana—it should—or whether marijuana legalization is about racial equity—it is. It is also no longer about whether all levels of government should redirect resources away from prosecution of marijuana and toward public health investments and community collaborations—they should,” the report says.
“Rather, the question is: When states legalize, how can they do so through a racial justice lens to address the panoply of harms that have been selectively aimed at Black and Latinx communities for decades?” it continues.
Although opponents of marijuana legalization have pointed to previous data showing ongoing racial disparities in enforcement post-prohibition as a reason to argue against the policy change, ACLU is very clear that their new report should not be used to push for continued criminalization.
“In short, legalization by itself means fewer black people getting arrested. Conversely, prohibition means more—many, many more—black people getting arrested, jailed, convicted,” Ezekiel Edwards, who authored the report and is the director of the organization’s Criminal Law Reform Project, said in an email. “So it would be wrong to suggest that legalization is a wash regarding alleviating the negative impacts of marijuana criminalization.”
He also cautioned against stopping at simply decriminalizing cannabis possession, a policy that some legalization opponents say they support as an alternative between incarceration and a commercial marijuana market, pointing out that there are “more black people getting arrested in states that decriminalized than those that have legalized.”
That said, he noted that “legalization on its own does not address the racial disparities in marijuana arrests or achieve racial equity more broadly in marijuana reform.”
It is crucial, Edwards argued, for states to “center legalization in racial justice.”
“This means not only including equity-focused legislation led and informed by communities directly harmed by prohibition, but also tethering legalization to changing the way police departments treat communities of color,” he said. “If marijuana is legalized without reducing racial profiling and the unnecessary harassment and surveillance of people because of the color of their skin or the neighborhood they live in, there will be a drop in marijuana arrests but no tangible impact on the racial disparities of those arrests, or on other arrests for other petty offenses regarding which we consistently find the police treating people differently based on race.”
Top IRS Official Says Marijuana Banking Reform Would Help Feds ‘Get Paid’
The Internal Revenue Service (IRS) would like to get paid—and it’d help if the marijuana industry had access to banks like companies in other legal markets, an official with the federal department said. She also talked about unique issues related to federal tax deductions for cannabis businesses.
At an event hosted by UCLA’s Annual Tax Controversy Institute on Thursday, IRS’s Cassidy Collins talked about the “special type of collection challenge” that the agency faces when it comes to working with cannabis businesses while the product remains federally illegal.
While IRS isn’t taking a stand on federal marijuana policy, Collins said that the status quo leaves many cannabis businesses operating on a cash-only basis, creating complications for the agency, in part by making it harder for banks to “pay us.”
“The reason why [the marijuana industry is] cash intensive is twofold,” she said. “Number one, a lot of customers don’t want a paper trail showing that they’re buying marijuana, and number two, the hesitancy of banks to allow marijuana businesses to even bank with them.”
Of course, the reason why many financial institutions remain hesitant to take on cannabis companies as clients is because the plant is a strictly controlled substance under federal law.
“There’s been a number of legislative bills that have been introduced—and I am definitely not expressing any opinion personally or on behalf of the IRS about any pending or proposed legislation,” Collins, who is a senior counsel in the IRS Office of Chief Counsel, said. “But it is interesting to note that, if the law changed so that the marijuana businesses could have banks, that would make the IRS’s job to collect [taxes] a lot easier. As part of collection, we want the money. That’s our end goal there.”
A major part of what makes cannabis businesses unique is that they don’t qualify for traditional tax credits under an IRS code known as 280E. That policy “prohibits them from claiming deductions for business expenses because they’re technically being involved in drug trafficking,” Collins explained at the event, from which small excerpts of her comments were reported by Bloomberg.
There are some options available to lessen the burden on marijuana firms, however. At the end of the day, “IRS will work with marijuana companies because, again, we want to get paid,” Collins said.
One of the ways the agency works with marijuana business operators is to have them visit designated IRS “tax assistance centers” that accept cash payments in excess of $50,000. But the official warned businesses to “be prepared to be there for a little while” as the center checks—and double checks—the amount of cash being submitted.
“Revenue officers will assist the marijuana companies in paying us,” she said.
IRS officials could also help cannabis firms by having officials accompany them “to the bank in order to try to help the taxpayer secure a cashier’s payment to pay the IRS, as well as using money orders,” she said, adding that “our revenue officers are are wanting to work with the marijuana companies to help assist them to pay us.”
“When the revenue officers are there in person with the taxpayer, that could potentially help increase the likelihood that the bank will cooperate and help the taxpayer transition into a cashier’s check,” she continued. “And that has been a trend since this first became legal [at the state level], that more and more banks are allowing cannabis companies to bank with them.”
In a report published earlier this year, congressional researchers examined tax policies and restrictions for the marijuana industry—and how those could change if any number of federal reform bills are enacted.
IRS, for its part, said last month that it expects the cannabis market to continue to grow, and it offered some tips to businesses on staying compliant with taxes while the plant remains federally prohibited.
As it stands, banks and credit unions are operating under 2014 guidance from the Financial Crimes Enforcement Network (FinCEN) that lays out reporting requirements for those that choose to service the marijuana industry.
Leaders in both chambers of Congress are working on legalization bills to end federal marijuana prohibition. But stakeholders are hopeful that, in the interim, legislators will enact modest marijuana banking reform. Legislation to protect financial institutions from being penalized for working with cannabis businesses passed the House for the fifth time last month.
Rodney Hood, a board member of the National Credit Union Administration, wrote in a Marijuana Moment op-ed this month that legalization is an inevitability—and it makes the most sense for government agencies to get ahead of the policy change to resolve banking complications.
IRS separately hosted a forum in August dedicated to tax policy for marijuana businesses and cryptocurrency.
Earlier this year, IRS Commissioner Charles Rettig told Congress that the agency would “prefer” for state-legal marijuana businesses to be able to pay taxes electronically, as the current largely cash-based system under federal cannabis prohibition is onerous and presents risks to workers.
Former Treasury Secretary Steven Mnuchin said in 2019 that he’d like to see Congress approve legislation resolving the cannabis banking issue and he pointed to the fact that IRS has had to build “cash rooms” to deposit taxes from those businesses as an example of the problem.
IRS released updated guidance on tax policy for the marijuana industry last year, including instructions on how cannabis businesses that don’t have access to bank accounts can pay their tax bills using large amounts of cash.
The update appears to be responsive to a Treasury Department internal watchdog report that was released earlier in the year. The department’s inspector general for tax administration had criticized IRS for failing to adequately advise taxpayers in the marijuana industry about compliance with federal tax laws. And it directed the agency to “develop and publicize guidance specific to the marijuana industry.”
Luxembourg Set To Become First European Country To Legalize Marijuana Following Government Recommendation
Luxembourg is poised to become the first European country to legalize marijuana, with key government agencies putting forward a plan to allow the possession and cultivation of cannabis for personal use.
The ministers of justice and homeland security on Friday unveiled the proposal, which will still require a vote in the Parliament but is expected to pass. It’s part of a broader package of reform measures the agencies are recommending.
Under the marijuana measure, adults 18 and older could grow up to four plants. However, under the non-commercial model that is being proposed, possessing more than three grams in public would still be a civil offense, carrying a fine of €25-500 ($29-581). Currently, the maximum fine for possession is €2,500 ($2,908).
In terms of access, adults would be able to buy and trade cannabis seeds for their home garden.
Justice Minister Sam Tamson said the government felt it “had to act” and characterized the home cultivation policy change as a first step, The Guardian reported.
👉🏻élaboration du projet de loi usage privé du #cannabis : jusqu’à 4 plantes à domicile & décorrectionnalisation <3g
👉🏻renforcement de la prévention & de l’accompagnement
👉🏻⬆️des moyens de la police
👉🏻élaboration d’un projet de production/vente #Luxembourg pic.twitter.com/8yre0Udt8J
— Sam Tanson (@SamTanson) October 22, 2021
“The idea is that a consumer is not in an illegal situation if he consumes cannabis and that we don’t support the whole illegal chain from production to transportation to selling where there is a lot of misery attached,” he said. “We want to do everything we can to get more and more away from the illegal black market.”
While limited in scope, the reform would make Luxembourg the first country in Europe to legalize the production and possession of marijuana for recreational use. Cannabis has been widely decriminalized in certain countries in the continent, but it has remained criminalized by statute.
Government sources in Luxembourg told The Guardian that plans are in the works to develop a program where the state regulates the production and distribution of marijuana. Tamson said they are working to resolve “international constraints” before taking that step, however, referring to United Nations treaty obligations that multiple U.S. states and other countries like Canada and Uruguay have openly flouted.
The measures include:
🟢 Regulation of cannabis use and cultivation: adults will be able to legally cultivate up to four cannabis plants for their own use, provided the cultivation is happening at their place of residence.
— European Greens (@europeangreens) October 22, 2021
For now, the country is focusing on legalization within a home setting. Parliament is expected to vote on the proposal in early 2022, and the ruling parties are friendly to the reform.
This has been a long time coming, as a coalition of major parties of Luxembourg agreed in 2018 to enact legislation allowing “the exemption from punishment or even legalization” of cannabis.
Meanwhile in the U.S., congressional lawmakers are working to advance legalization legislation. A key House committee recently approved a bill to end marijuana prohibition, and Senate leadership is finalizing a separate reform proposal.
In Mexico, a top Senator said this week that lawmakers could advance legislation to regulate marijuana in the coming weeks. The Supreme Court has already ruled that adults cannot be criminalized over possession or cultivation, but there’s currently no program in place to provide access.
Photo courtesy of Mike Latimer.
New Bipartisan Marijuana Research Bill In Congress Would Let Scientists Study Dispensary Products
A bipartisan group of federal lawmakers introduced a bill on Thursday to remove barriers to conducting research on marijuana, including by allowing scientists to access cannabis from state-legal dispensaries.
The Medical Marijuana Research Act, filed by the unlikely duo of pro-legalization Rep. Earl Blumenauer (D-OR) and prohibitionist Rep. Andy Harris (R-MD), would streamline the process for researchers to apply and get approved to study cannabis and set clear deadlines on federal agencies to act on their applications.
“Congress is hopelessly behind the American people on cannabis, and the quality of our research shows why that is an urgent problem,” Blumenauer told Marijuana Moment. “Despite the fact that 99 percent of Americans live in a state that has legalized some form of cannabis, federal law is still hamstringing researchers’ ability to study the full range of health benefits offered by cannabis, and to learn more about the products readily available to consumers.”
“It’s outrageous that we are outsourcing leadership in that research to Israel, the United Kingdom, Canada, and others. It’s time to change the system,” he said.
Late last year, the House approved an identical version of the cannabis science legislation. Days later, the Senate passed a similar bill but nothing ended up getting to the president’s desk by the end of the last Congress. Earlier this year, a bipartisan group of senators refiled their marijuana research measure for the current 117th Congress.
Meanwhile, lawmakers are also advancing a separate strategy to open up dispensary cannabis to researchers. Large-scale infrastructure legislation that has passed both chambers in differing forms and which is pending final action contains provisions aimed at allowing researchers to study the actual marijuana that consumers are purchasing from state-legal businesses instead of having to use only government-grown cannabis.
The new bill filed this week by Blumenauer and Harris, along with six other original cosponsors, would also make it easier for scientists to modify their research protocols without having to seek federal approval.
Marijuana Moment is already tracking more than 1,200 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
It would additionally mandate that the Drug Enforcement Administration (DEA) license more growers and make it so there would be no limit on the number of additional entities that can be registered to cultivate marijuana for research purposes. It would also require the U.S. Department of Health and Human Services (HHS) to submit a report to Congress within five years after enactment to overview the results of federal cannabis studies and recommend whether they warrant marijuana’s rescheduling under federal law.
“The cannabis laws in this country are broken, including our laws that govern cannabis research,” Blumenauer said in remarks in the Congressional Record. “Because cannabis is a Schedule I substance, researchers must jump through hoops and comply with onerous requirements just to do basic research on the medical potential of the plant.”
The new legislation will “both streamline the often-duplicative licensure process for researchers seeking to conduct cannabis research and facilitate access to an increased supply of higher quality medical grade cannabis for research purposes,” he said, adding that expanded studies will help make sure “Americans have adequate access to potentially transformative medicines and treatments.”
For half a century, researchers have only been able to study marijuana grown at a single federally approved facility at the University of Mississippi, but they have complained that it is difficult to obtain the product and that it is of low quality. Indeed, one study showed that the government cannabis is more similar to hemp than to the marijuana that consumers actually use in the real world.
There’s been bipartisan agreement that DEA has inhibited cannabis research by being slow to follow through on approving additional marijuana manufacturers beyond the Mississippi operation, despite earlier pledges to do so.
In May, the agency finally said it was ready to begin licensing new cannabis cultivators. Last week, DEA proposed a large increase in the amount of marijuana—and psychedelics such as psilocybin, LSD, MDMA and mescaline—that it wants produced in the U.S. for research purposes next year.
Under the new House bill, the agency would be forced to start approving additional cultivation applications for study purposes within one year of the legislation’s enactment.
HHS and the attorney general would be required under the bill to create a process for marijuana manufacturers and distributors to supply researchers with cannabis from dispensaries. They would have one year after enactment to develop that procedure, and would have to start meeting to work on it within 60 days of the bill’s passage.
In general, the legislation would also establish a simplified registration process for researchers interested in studying cannabis, in part by reducing approval wait times, minimizing costly security requirements and eliminating additional layers of protocol review.
Read the full text of the new marijuana research bill below: